WESTFORD, Mass., June 25 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced the opening of its second sales office in the People's Republic of China. Located in the Chao Yang District of Beijing, the office will be headed by Aileen Ren, vice general manager of sales and marketing for Cynosure China, the company's wholly owned subsidiary. Cynosure also has a sales office in Suzhou, located approximately an hour northwest of Shanghai.
"Consistent with our strategy, we are continuing to broaden the global reach of our newest aesthetic laser systems in key international markets," said President and Chief Executive Officer Michael Davin. "China, with its rapidly growing affluent middle class and the world's largest population, is an important region for Cynosure. We have operated in the People's Republic since 1995 and in 2006 we became the first U.S. aesthetic laser company to establish a wholly owned subsidiary there. Following on the successful introduction of our Elite(TM) family of workstations in China last year, we are continuing to pursue additional regulatory approvals of our flagship products for this expanding market."
About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.
For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com.
This press release about future expectations, plans and prospects for
Cynosure in the People's Republic of China includes forward-looking
statements within the meaning of The Private Securities Litigation Reform
Act of 1995. These statements contain the words "believes," "anticipates,"
plans," "expects," "will" and similar expressions. Actual results may
differ materially from those indicated by such forward-looking statements
as a result of various important factors, including Cynosure's history of
operating losses, its reliance on sole source suppliers, the inability to
accurately predict Cynosure's success in China, changes in consumer
preferences, competition in the aesthetic laser industry, as well as
economic, market, technological and other factors discussed in Cynosure's
most recent Annual Report on Form 10-K, which is filed with the Securities
and Exchange Commission. In addition, the forward-looking statements
included in this press release represent Cynosure's views as of the date of
this press release. Cynosure anticipates that subsequent events and
developments will cause its views to change. However, while Cynosure may
elect to update these forward- looking statements at some point in the
future, it specifically disclaims any obligation to do so. These
forward-looking statements should not be relied upon as representing
Cynosure's views as of any date subsequent to the date of this press
Sharon Merrill Associates, Inc.
|SOURCE Cynosure, Inc.|
Copyright©2008 PR Newswire.
All rights reserved